GLP-1 receptor agonists like semaglutide and tirzepatide act on incretin pathways through GLP-1 and GIP receptors, with central appetite suppression and slowed gastric emptying as primary mechanisms
A common feature is immune dysregulation, where, in Graves disease, autoantibodies stimulating the thyroid to produce an excessive amount of hormone and, in Hashimotos thyroiditis, the thyroid gland suffers autoimmune destruction (Bari et al
These medications are used within a structured medical weight-loss program, where dosing, nutrition, and follow-up are personalized to your needs
Stay on top of research as further data emerges
The wellness industry has seized on this, marketing synthetic peptides as a way to 'hack' your body's natural processes
The resulting energy deficit manifests clinically as debilitating fatigue and post-exertional malaise (PEM), hallmark symptoms of both Long COVID and ME/CFS